Taglich Brothers Forecasts Lower Earnings for Cosmos Health

Cosmos Health Inc. (NASDAQ:COSM) – Research analysts at Taglich Brothers lowered their FY2024 earnings estimates for shares of Cosmos Health in a research report issued to clients and investors on Monday, November 25th. Taglich Brothers analyst H. Halpern now expects that the company will earn ($0.78) per share for the year, down from their previous forecast of ($0.48). The consensus estimate for Cosmos Health’s current full-year earnings is ($0.48) per share. Taglich Brothers also issued estimates for Cosmos Health’s Q4 2024 earnings at ($0.09) EPS, Q1 2025 earnings at ($0.03) EPS, Q2 2025 earnings at $0.01 EPS and FY2025 earnings at $0.01 EPS.

Cosmos Health Stock Up 3.2 %

COSM stock opened at $0.81 on Thursday. The firm has a market cap of $18.91 million, a PE ratio of -0.33 and a beta of 5.72. Cosmos Health has a 1 year low of $0.47 and a 1 year high of $1.65. The company has a fifty day simple moving average of $0.77 and a 200 day simple moving average of $0.91. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.